![These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006 These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=veregen-02.jpg&id=581570)
These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006
![These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006 These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=veregen-01.jpg&id=581570)
These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006
![A trial of Veregen cream for women with vulval intraepithelial neoplasia (EPIVIN) | Cancer Research UK A trial of Veregen cream for women with vulval intraepithelial neoplasia (EPIVIN) | Cancer Research UK](https://www.cancerresearchuk.org/sites/default/files/styles/cruk_wide_resp_breakpoint_one/public/11782_randomisation.png?itok=qWXJvmlp)
A trial of Veregen cream for women with vulval intraepithelial neoplasia (EPIVIN) | Cancer Research UK
![These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006 These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=veregen-03.jpg&id=581570)
These highlights do not include all the information needed to use VEREGEN® safely and effectively. See full prescribing information for VEREGEN®. Veregen ® (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006
![A trial of Veregen cream for women with vulval intraepithelial neoplasia (EPIVIN) | Cancer Research UK A trial of Veregen cream for women with vulval intraepithelial neoplasia (EPIVIN) | Cancer Research UK](https://www.cancerresearchuk.org/sites/default/files/styles/cruk_wide_resp_breakpoint_one/public/11782-bar-chart-2.png?itok=1096CuNi)
A trial of Veregen cream for women with vulval intraepithelial neoplasia (EPIVIN) | Cancer Research UK
![Molecules | Free Full-Text | Applications of a Standardized Green Tea Catechin Preparation for Viral Warts and Human Papilloma Virus-Related and Unrelated Cancers Molecules | Free Full-Text | Applications of a Standardized Green Tea Catechin Preparation for Viral Warts and Human Papilloma Virus-Related and Unrelated Cancers](https://www.mdpi.com/molecules/molecules-25-02588/article_deploy/html/images/molecules-25-02588-g001.png)